Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-16

FDA Approved: OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES — Supplemental Application (GE Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for Optison perflutren protein-type A microspheres (human albumin microspheres and perflutren) from GE Healthcare. The a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Optison

Snippet

SUPPL AP for OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)